Earnings Feed
Start Free
Home/Filings/4/0001209191-21-045643
4//SEC Filing

Drazba Brian G. 4

Accession 0001209191-21-045643

CIK 0001262104other
View on SEC.govCompany Profile

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 6:51 PM ET

Size

13.9 KB

Accession

0001209191-21-045643

Insider Transaction Report

Form 4
Period: 2021-07-01
MEI Pharma, Inc.MEIP
Drazba Brian G.
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-07-01+200,000→ 200,000 total
    Exercise: $2.95Exp: 2031-07-01→ Common Stock (200,000 underlying)
Holdings

  • Stock Option (Right to Buy)

    Exercise: $4.33Exp: 2028-06-22→ Common Stock (130,000 underlying)
    130,000

  • Stock Option (Right to Buy)

    Exercise: $4.28Exp: 2028-07-12→ Common Stock (100,000 underlying)
    100,000

  • Stock Option (Right to Buy)

    Exercise: $2.52Exp: 2029-07-01→ Common Stock (230,000 underlying)
    230,000

  • Stock Option (Right to Buy)

    Exercise: $1.59Exp: 2027-04-03→ Common Stock (150,000 underlying)
    150,000

  • Stock Option (Right to Buy)

    Exercise: $2.83Exp: 2027-07-06→ Common Stock (50,000 underlying)
    50,000

  • Stock Option (Right to Buy)

    Exercise: $3.49Exp: 2030-07-02→ Common Stock (230,000 underlying)
    230,000
Footnotes (7)
  • [F1]One-quarter of such options shall vest on July 1, 2022 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022.
  • [F2]All of such options are presently exercisable.
  • [F3]One-quarter of such options vested on July 6, 2018 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 6, 2018.
  • [F4]One-quarter of such options vested on June 22, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on June 22, 2019.
  • [F5]One-quarter of such options vested on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019.
  • [F6]One-quarter of such options vested on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.
  • [F7]One-quarter of such options vested on July 2, 2021 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021.

Documents

1 file

Issuer

MEI Pharma, Inc.

CIK 0001262104

→
Entity typeother

Related Parties

1
  • filerCIK 0001507369

Filing Metadata

Form type
4
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 6:51 PM ET
Size
13.9 KB
View on SEC.gov